Agree.net – Lifestyle
Author:
Boundless Bio, Inc.
Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting
April 17, 2026
Boundless Bio Announces Upcoming Presentation of Oral Kinesin Degrader Program at the American Association for Cancer Research Annual Meeting 2026
March 17, 2026
Boundless Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
March 9, 2026